Israel Englander Aquestive Therapeutics, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q2 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,979,840 shares of AQST stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,979,840
Previous 258,216
1054.01%
Holding current value
$11.3 Million
Previous $748,000
1218.58%
% of portfolio
0.01%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding AQST
# of Institutions
126Shares Held
47.6MCall Options Held
64.2KPut Options Held
204K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$37.1 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$20.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$16.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.19MShares$8.28 Million0.32% of portfolio
-
Geode Capital Management, LLC Boston, MA1.98MShares$7.47 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $202M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...